Treatment of recurrent hepatitis C following liver transplantation

被引：0

作者：

Meyer D. ^{[1
]}

Shetty K. ^{[1
]}

机构：

[1] Georgetown University Hospital, Washington, DC 20007, 2 Main, 3800 Reservoir Road, NW

来源：

Current Hepatitis Reports | 2007年 / 6卷 / 2期

关键词：

Sustained Virologic Response; Sustained Virologic Response Rate; Liver Transplant Recipient; Acute Cellular Rejection; Follow Liver Transplantation;

D O I：

10.1007/s11901-007-0004-9

中图分类号：

学科分类号：

摘要：

Patients with chronic hepatitis C infection who are viremic at the time of liver transplantation will have universal recurrence of the virus in the allograft. Long-term survival after transplantation in patients with chronic hepatitis C is diminished as compared with patients who undergo liver transplantation for other indications. The progression of HCV-related fibrosis and the development of cirrhosis appear to be accelerated in the presence of immunosuppression, compared with an immune-competent population. The primary aim of hepatitis C treatment in patients with recurrent hepatitis C infection in the allograft remains eradication of the virus to prevent the progression of liver disease. However, decisions regarding the timing, duration, and optimization of the treatment regimen must be tailored to the individual. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：54 / 59

页数：5

共 37 条

[1]

Organ Procurement and Transplantation Network (OPTN) database

[2]

Davis G.L., Albright J.E., Cook S.F., Rosenberg D.M., Projecting the future healthcare burden from hepatitis C in the United States, Liver Transpl, 9, pp. 331-338, (2003)

[3]

Berenguer M., Prieto M., Rayon J.M., Et al., Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation, Hepatology, 32, pp. 852-858, (2000)

[4]

Berenguer M., Ferrell L., Watson J., Et al., HCV-related fibrosis progression following liver transplantation: Increase in recent years, J Hepatology, 32, pp. 673-684, (2000)

[5]

Forman L.M., Lewis J.D., Berlin J.A., Et al., The association between hepatitis C infection and survival after orthotopic liver transplantation, Gastroenterology, 122, pp. 889-896, (2002)

[6]

Garcia-Retortillo M., Forns X., Feliu, Et al., Hepatitis C virus kinetics during and immediately after liver transplantation, Hepatology, 35, pp. 680-687, (2002)

[7]

Schluger L.K., Sheiner P.A., Thung S.N., Et al., Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation, Hepatology, 23, pp. 971-976, (1996)

[8]

Charlton M., Seaberg E., Wiesner R., Et al., Predictors of patient and graft survival following liver transplantation for hepatitis C, Hepatology, 28, pp. 823-830, (1998)

[9]

Thuluvath P., Yoo H., Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation, Liver Transpl, 10, pp. 1263-1268, (2004)

[10]

Garcia-Retortillo M., Forns X., Llovet J., Et al., Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation, Hepatology, 40, pp. 699-707, (2004)

← 1 2 3 4 →